Zydus Cadila agrees sub-licensing deal with MPP

08-07-2016

Zydus Cadila agrees sub-licensing deal with MPP

Green Apple/shutterstock.com

Healthcare provider Zydus Cadila has signed a sub-licensing agreement with the Medicines Patent Pool (MPP) centring on the generic production of Daklinza (daclatasvir).


Zydus Cadila, MPP, Bristol-Myers Squibb, Daklinza

LSIPR